Hungary buys Russia's Sputnik V vaccine, first in EU, minister says

In a live video posted on his Facebook page, Szijjarto told a joint briefing with Russia's health minister that the vaccines would arrive in three tranches, and that details about the size of the shipments would be released later. The agreement comes days after Hungary's drug regulator gave approval for use of Britain's AstraZeneca and Russia's Sputnik V vaccines against the coronavirus, as Budapest strives to lift coronavirus lockdown measures to boost the economy.

Reuters | Updated: 22-01-2021 14:41 IST | Created: 22-01-2021 14:09 IST
Hungary buys Russia's Sputnik V vaccine, first in EU, minister says
Representative image Image Credit: Flickr

Hungary has signed a deal to buy Russia's Sputnik V COVID-19 vaccine, the first European Union country to do so, Foreign Minister Peter Szijjarto told a briefing during talks in Moscow on Friday. In a live video posted on his Facebook page, Szijjarto told a joint briefing with Russia's health minister that the vaccines would arrive in three tranches, and that details about the size of the shipments would be released later.

The agreement comes days after Hungary's drug regulator gave approval for use of Britain's AstraZeneca and Russia's Sputnik V vaccines against the coronavirus, as Budapest strives to lift coronavirus lockdown measures to boost the economy. The EU's medicines regulator has yet to approve the Russian or AstraZeneca vaccine. "I am very happy to announce that we have signed an agreement today under which Hungary can purchase a large quantity of Russia's vaccine in three tranches," Szijjarto said.

He said this could allow Hungary to lift restrictions to curb the pandemic sooner. The European Medicines Agency (EMA) is expected to decide on the vaccine developed by AstraZeneca and Oxford University on Jan. 29.

Scientists have raised concern about the speed at which Moscow has launched its vaccine, giving the regulatory go-ahead for the shot at home and beginning mass vaccinations before full trials to test its safety and efficacy had been completed. Moscow has said Sputnik V is 92% effective at protecting people from COVID-19 based on interim results, but has not yet released the full dataset for the trials.

Russia on Wednesday filed for registration of the Sputnik V vaccine in the EU before an EMA review next month.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Why unequal access to coronavirus vaccines is a threat to us all

... ...

India’s love affair with fossil fuels: the path to sustainable development?

... ...

Videos

Latest News

In Iraq, pope to visit Mosul churches desecrated by Islamic State

In Mosul, adjacent to the Biblical city of Nineveh, four churches representing different denominations occupy a small square surrounded by low-rise houses, testament to the role Iraqs once flourishing Christian community played.Today, all f...

CBSE to hold training sessions for schools on restructured affiliation process

The Central Board of Secondary Education CBSE is planning a series of webinars and training sessions for schools to familiarise them about the newly restructured affiliation process, according to officials.CBSE has restructured the affiliat...

FPIs net buyers for 2nd consecutive month in Feb; invest Rs 23,663 cr

Remaining net buyers for second consecutive month in this calendar year, overseas investors pumped in Rs 23,663 crore in Indian markets in February on account of positive sentiment due to the Union Budget 2021-22 and strong third quarter ea...

Increase public health care budget in Maharashtra: Activists

Health care activists in Maharashtra have demanded an increase in the public health budget by one-and-a-half times and implementation of a central governments legislation which provides for capping treatment rates in private hospitals.The C...

Give Feedback